Stathmin

File:PDB 1z2b EBI.jpg

PDB_1z2b_EBI.jpg

Stathmin is a highly conserved protein that plays a crucial role in the regulation of the microtubule dynamics within the cell. It is also known as oncoprotein 18 (Op18), phosphoprotein p19, 19K, and metablastin. Stathmin is encoded by the STMN1 gene in humans.

Structure

Stathmin is a small, cytoplasmic phosphoprotein composed of 149 amino acids. It contains several phosphorylation sites that are critical for its function. The protein has a coiled-coil structure that allows it to interact with tubulin and other microtubule-associated proteins.

Function

Stathmin regulates microtubule dynamics by promoting microtubule depolymerization. It binds to tubulin heterodimers, preventing their polymerization into microtubules. This activity is regulated by phosphorylation; when stathmin is phosphorylated, its ability to bind tubulin is inhibited, allowing microtubule polymerization to proceed.

Role in Cell Cycle

Stathmin is involved in the regulation of the cell cycle, particularly during mitosis. It ensures proper spindle formation and function, which is essential for accurate chromosome segregation. Dysregulation of stathmin activity can lead to aneuploidy and has been implicated in cancer development.

Clinical Significance

Overexpression of stathmin has been observed in various types of cancer, including breast cancer, leukemia, and lymphoma. Due to its role in cell division and its overexpression in tumors, stathmin is considered a potential target for cancer therapy. Inhibitors of stathmin function are being explored as therapeutic agents.

Research

Ongoing research is focused on understanding the precise mechanisms by which stathmin regulates microtubule dynamics and its role in cancer progression. Studies are also investigating the potential of stathmin as a biomarker for cancer diagnosis and prognosis.

See also

• Microtubule
• Tubulin
• Cell cycle
• Mitosis
• Cancer